*By Madison Alworth* Siri can play your jam on demand and Alexa gives you the weather, but the app makers behind Hugging Face really want to be there for you when you need a laugh, some encouragement, or friendly advice. That's the promise of the artificial intelligence chatbot, designed to exchange messages, emojis, and life lessons with a generation of users desperate for a response whenever they text ー teenagers. "Ultimately, we think that everyone will chat with an A.I. everyday, all day," said Clément Delangue, a co-founder and the CEO of Hugging Face. "But as for most new technology and mainstream technologies, they were the first to adopt it." Though teenagers may be the first cohort willing to accept A.I. B.F.F.s, Delangue said anyone can befriend Hugging Face, which will attempt to respond to text queries with personalized responses as the app begins to "care" about you, but not exactly the way a human might. "A dog, a cat is a different form of intelligence. It's not a human form of intelligence," Delangue said in an interview Tuesday with Cheddar. "But you really enjoy playing with your cat or with your dog every day, and you create some form of emotional attachment." Hugging Face is designed to mimic this sort of unconditional relationship using A.I. "We think the same thing is going to happen for artificial intelligence, meaning everyone will have their A.I. B.F.F. that they're going to chat with every day," Delangue said. Hugging Face has already made some well-heeled friends. It raised $1.2 million in pre-seed funding last year and recently raised $4 million in a seed round led by Ronny Conway of a_capital, an early investor in Instagram. Delangue said that the investments will help the company to develop its technology without worrying about having to make money for the next few years. Hugging Face is available as a stand-alone app and as an add-on for Facebook Messenger. For the full interview, [click here](https://cheddar.com/videos/new-chatbot-wants-to-be-your-bff).

Share:
More In Technology
New York Auto Show Puts Big Focus on Electric Vehicles
Lisa Whalen, Automotive and Mobility Analyst at Morning Consult, joined Cheddar News' Closing Bell to break down the famed auto show's emphasis on electric vehicles this year, reflecting a shift toward electrification in the automotive industry.
What Spending 665 Days in Space Feels Like
Peggy Whitson, Director of Human Space Flight, Axiom Space, joins Cheddar Innovates to discuss Axiom's involvement in the first fully-private mission to the ISS, and her experience spending 665 days in space.
Living in Outer Space; A New-Age Twist on Millenia-Old Remedies
On this episode of Cheddar Innovates, Peggy Whitson, Director of Human Space Flight, Axiom Space, breaks down Axiom's involvement in the first fully-private mission to the ISS, and her experience spending 665 days in space; William Li and Danielle Chang, co-founders of The Hao Life, discuss how they're shaking up the $71 billion supplement industry by putting a modern spin on traditional natural Chinese remedies; Cheddar gets a look at Curiosity Stream's 'Sagrada Familia: Gaudi's Challenge.'
Pillow Customization to Improve Sleep; Bringing Green Hydrogen to Scale
On this episode of Cheddar Innovates: President of The Pillow Bar breaks down how everyone can benefit from a pillow customized to their unique way of sleeping; CEO of H2Pro explains how to bring environmentally friendly hydrogen to scale; Cheddar gets a look at Curiosity Stream's 'Suppressed Science.'
Gardening to Improve Wellbeing; Future of A.I. in Healthcare
On this episode of Cheddar Innovates: Gardenuity CEO breaks down how gardening can improve your wellbeing; Augmedix CEO discusses how this technology is helping doctors fight burnout; Cheddar gets a look at Curiosity Stream's 'Suppressed Science.'
Innovation in Prosthetics; New Drug for Anti-Aging
On this episode of Cheddar Innovates: Atom Limbs CEO breaks down how the Atom Touch prosthetic is different from other prosthetics on the market; CEO & Chief Scientific Officer of MyMD explains how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases; A look at Curiosity Stream's 'The Future of Warfare.'
Load More